who found that the proportion of TIM3-positive NK cells (CD56+TIM3+) was significantly increased in patients with MDS and, together with CD8+TIM3+T cells and CD4+TIM3+T cells, constituted the immune signature of poor prognosis. This evidence concerns the gene HAVCR2 and myelodysplastic syndrome.